← back to search

S. Mark Tompkins

University of Georgia · US
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Influenza Virus Research Studies, Respiratory viral infections research, Animal Disease Management and Epidemiology, and Viral gastroenteritis research and epidemiology.
h-index
39
citations
5,806
works
182
NIH funding
primary concept
email

Recent publications

Receptor-binding specificity of a bovine influenza A virus
Nature 2025cited by 28position: middledoi
Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns
Journal of Virology 2025cited by 25position: middledoi
A general computational design strategy for stabilizing viral class I fusion proteins
Nature Communications 2024cited by 13position: middledoi
Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection
Journal of Virological Methods 2024cited by 12position: lastdoi
Pandemic Risk Assessment for Swine Influenza A Virus in Comparative In Vitro and In Vivo Models
Viruses 2024cited by 2position: lastdoi
Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection
SSRN Electronic Journal 2024cited by 2position: lastdoi
Pandemic Risk Assessment for a Swine Influenza A Virus in Comparative Human Substrates
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 1position: lastdoi
4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses
PLoS Pathogens 2023cited by 39position: middledoi
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model
Frontiers in Immunology 2023cited by 7position: middledoi
Development and characterization of an immortalized swine respiratory cell line for influenza A virus research
Frontiers in Veterinary Science 2023cited by 4position: middledoi
A general computational design strategy for stabilizing viral class I fusion proteins
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 4position: middledoi
Quantifying Biomolecular Interactions Using Slow Mixing Mode (SLOMO) Nanoflow ESI-MS
ACS Central Science 2022cited by 29position: middledoi
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2
Nature Chemical Biology 2021cited by 261position: middledoi
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
ACS Central Science 2021cited by 188position: middledoi
Characterizing Emerging Canine H3 Influenza Viruses
PLoS Pathogens 2020cited by 44position: middledoi
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
Antimicrobial Agents and Chemotherapy 2018cited by 240position: middledoi
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge
Journal of Virology 2018cited by 45position: middledoi
Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity
Nanomedicine Nanotechnology Biology and Medicine 2016cited by 34position: middledoi
Novel H7N9 Influenza Virus Shows Low Infectious Dose, High Growth Rate, and Efficient Contact Transmission in the Guinea Pig Model
Journal of Virology 2013cited by 50position: middledoi
Gain-of-Function Experiments on H7N9
Science 2013cited by 28position: middledoi
Low Pathogenic Avian Influenza Isolates from Wild Birds Replicate and Transmit via Contact in Ferrets without Prior Adaptation
PLoS ONE 2012cited by 28position: lastdoi

Grants

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
NIH75N93021C00018-P00007-9999-1$3,539,3262021–2024Contact PIRePORTER
CENTER OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
NIH75N93021C00018-0-9999-4$3,010,1312021–2022Contact PIRePORTER
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
NIH75N93021C00018-P00012-9999-2$2,303,8022021–2026Contact PIRePORTER
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
NIH75N93021C00018-P00005-9999-2$2,292,1232021–2024Contact PIRePORTER
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
NIH75N93021C00018-P00016-9999-2$2,241,2562021–2027Contact PIRePORTER
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
NIH75N93021C00018-P00007-9999-2$2,079,4652021–2024Contact PIRePORTER
NIAID Centers of Excellence for Influenza Research and Response
NIH75N93021C00018-P00016-9999-1$1,574,0812021–2027Contact PIRePORTER
NIAID Centers of Excellence for Influenza Research and Response
NIH75N93021C00018-P00012-9999-1$1,314,2442021–2026Contact PIRePORTER
CEIRR: SARS-COV-2 Research Activities
NIH75N93021C00018-P00007-9999-3$1,251,9012021–2024Contact PIRePORTER
NIAID Centers of Excellence for Influenza Research and Response
NIH75N93021C00018-P00012-9999-4$600,0002021–2026Contact PIRePORTER
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
NIH75N93021C00018-0-9999-2$600,0002021–2022Contact PIRePORTER
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
NIH75N93021C00018-P00005-9999-1$418,8742021–2024Contact PIRePORTER
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
NIH75N93021C00018-0-9999-1$300,0002021–2022Contact PIRePORTER
CEIRR: SARS-COV-2 Research Activities
NIH75N93021C00018-0-9999-3$100,0002021–2022Contact PIRePORTER

Frequent collaborators

Constantinos S. Kyriakis · Auburn University6 papers (2023–2024)Elizabeth W. Howerth · Georgia College & State University4 papers (2012–2024)Peter J. Neasham · Center for Surveillance, Epidemiology, and Laboratory Services4 papers (2023–2024)Madelyn Krunkosky · University of Georgia4 papers (2024–2024)Vasilis C. Pliasas · Center for Surveillance, Epidemiology, and Laboratory Services4 papers (2023–2024)Scott K. Johnson · University of Georgia3 papers (2013–2023)Stacey Schultz‐Cherry · Yale University3 papers (2013–2024)Richard J. Webby · Massey University3 papers (2013–2025)Geert‐Jan Boons · Utrecht University3 papers (2021–2025)Pradeep Chopra · Brown University3 papers (2021–2025)Anice C. Lowen · Emory University3 papers (2013–2025)Ian Padykula · University of Georgia3 papers (2023–2024)Robert P. de Vries · Utrecht University3 papers (2021–2025)Ralph A. Tripp · University of Georgia3 papers (2013–2016)Thomas M. Krunkosky · University of Georgia2 papers (2024–2024)Zachary M. Sticher · Emory University2 papers (2018–2023)Ling Han · Anhui University2 papers (2021–2022)Avik Banerjee · University of Illinois Chicago2 papers (2023–2024)Richard W. Compans · Emory University2 papers (2013–2016) · 2 papers (2018–2023)